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Abstract
Numerous studies have established that estimated brain age, as derived from sta-
tistical models trained on healthy populations, constitutes a valuable biomarker
that is predictive of cognitive decline and various neurological diseases. In this
work, we curate a large-scale heterogeneous dataset (N = 10,158, age range 18
- 97) of structural brain MRIs in a healthy population from multiple publicly-
available sources, upon which we train a deep learning model for brain age
estimation. The availability of the large-scale dataset enables a more uniform
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tigators can be found at: http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/
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age distribution across adult life-span for effective age estimation with no bias
toward certain age groups. We demonstrate that the age estimation accuracy,
evaluated with mean absolute error (MAE) and correlation coefficient (r), out-
performs previously reported methods in both a hold-out test set reflective of
the custom population (MAE = 4.06 years, r = 0.970) and an independent
life-span evaluation dataset (MAE = 4.21 years, r = 0.960) on which a previous
study has evaluated. We further demonstrate the utility of the estimated age in
life-span aging analysis of cognitive functions. Furthermore, we conduct exten-
sive ablation tests and employ feature-attribution techniques to analyze which
regions contribute the most predictive value, demonstrating the prominence of
the frontal lobe as well as pattern shift across life-span.
In summary, we achieve superior age estimation performance confirming
the efficacy of deep learning and the added utility of training with data both
in larger number and more uniformly distributed than in previous studies. We
demonstrate the regional contribution to our brain age predictions through mul-
tiple routes and confirm the association of divergence between estimated and
chronological brain age with neuropsychological measures.
Keywords: brain-age, MRI, deep learning, normal aging, adult life-span
1. Introduction
Age estimation is the task of estimating an individual’s age based on a set
of other covariates. In particular, a large body of research focuses on the task
of predicting brain age based on imaging studies. In addition to its utility in
studying the aging process itself, estimated age, as derived from models trained
on a healthy population, has emerged as a useful biomarker for diseases. Specif-
ically, the divergence of one’s estimated age from chronological age has been
associated with various diseases, especially those thought to mimic an advanced
age state.
Typically, models for estimating brain age are trained on datasets repre-
senting a normal aging population free of obvious disease. When subsequently
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applied on (possibly abnormal) subjects, predicted brain age has been linked
to education and self-reported physical activity [1] and has been utilized to
characterize diseases including Alzheimer’s Disease (AD) [2], schizophrenia [3],
traumatic brain injury [4], etc., where deviation from normal aging trajectory
occurs alongside disease state.
There are three components necessary to determine brain age with this
paradigm: 1) covariates: the measured brain characteristics which serve as
inputs to the model, 2) dataset: the precise cohort of normal aging subjects
upon which the model is trained, 3) model: the precise algorithms used to
estimate the brain age given the available covariates.
While brain characteristics can be derived via many methods, neuroimaging
is the most common and comprehensive way to characterize the “brain state”
in vivo. Within neuroimaging, past studies have addressed EEG (Electroen-
cephalogram) [5], DTI (diffusion tensor imaging) [6], and resting state BOLD
fMRI (blood-oxygen-level dependent functional MRI) [7], which reflect differ-
ent physiological brain measures. However, T1-weighted (T1w) structural MRI,
which reveals features of the underlying anatomical characteristics of the brain,
including gray and white matter delineation and gyral and sulcal patterns, is the
most common modality in brain age estimation research. Imaging-derived neu-
roanatomical characteristics are biomarkers particularly sensitive to the aging
process [8]. Practically, as one most widely available and standardized neu-
roimaging modalities, T1w structural MRI can be easily acquired for a large
population. And within structural MRI domain, studies have used derived
summary variables such as regional volumes or thickness estimation [9], requir-
ing additional software processing to generate such values, and also unprocessed
MRI scans [10].
We believe that for these tools to be broadly useful, they must be trained
on adequately diverse datasets that reflect the diversity of the populations on
which the model might potentially be deployed. In this study, we propose using
a dataset aggregated from several publicly available multi-center neuroimaging
datasets, representing a diverse healthy population. This healthy study pop-
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ulation is both larger in scale than those investigated by most previous age
estimation studies and specifically designed to enable training age estimation
models with an approximately uniform age distribution across the adult life
span.
Lastly, given a study population and selected brain characteristics, the age
is estimated based on statistical machine learning techniques. Another way to
formulate the age estimation problem is to extract generalizable features from
the brain that best capture the chronological age of a person provided the indi-
vidual is undergoing a typical aging process that is present in a general healthy
population. Numerous traditional machine learning methods have been pro-
posed for age estimation including relevance vector machines [11, 12], Gaussian
processes [13, 14], random forests [15], hidden Markov models [16], and non-
negative matrix factorization [17].
More modern deep learning based methods are especially well suited to this
task provided enough training data, and have been previously applied by [10]
who demonstrated favorable performance. Interpretability is a critical aspect
of deep neural network based method. We seek not only to achieve predictive
performance, but also to derive insights by understanding which features are
most predictive. In this work, we explore regional contributions in the regression
task by considering both feature ablation experiments and an activation map
based post hoc interpretation method.
In summary, we utilize a 3D deep convolutional neural network based regres-
sion model to estimate age using T1w structural MRI volumes from a diverse
multi-study population that is sampled with even age distribution across adult
age span. We achieved superior performance both in the hold-out test set from
the same population and also in an independent life-span evaluation dataset.
The deviance of the estimated age from chronological age is linked to neu-
ropsychological and neuromorphometric measures. We further demonstrate the
prominence of frontal lobe in brain age estimation, and the pattern variability
across life-span.
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2. Method
In this section, we first describe the population and the experimental setup
used in this study. We then describe the MRI pre-processing steps and the con-
volutional neural network used to estimate age. Next, given our learned model
for estimating brain age, we present analysis that associates the divergence of
the estimated age from the chronological brain age with neuropsychological and
neuromorphometric measures. Finally, we describe multiple modes of region-
ality analysis for identifying which regions are most predictive. These consist
of both ablation experiments and an extension of the class activation mapping
method for interpreting feature importance in deep networks to the regression
setting.
2.1. Study Population
It is necessary to build an adequate neuroimaging dataset for age prediction
in the full adult life span, especially given study recruitment criteria the dataset
is not necessarily evenly distributed across age. Increased participation in open
data consortia and imaging datasets greatly facilitates the collection of such
data. In this work, we collect more than 30,000 T1w MRI scans from multiple
open neuroimaging datasets. The list of the datasets used in this study with the
full names and sources are listed in supplementary Table S2. Among those, we
only include subjects with clear indication of normal neurological evaluations
contingent on the individual data providers criteria for a subject that is con-
sidered free of disease. Specifically, we exclude subjects with any neurological
or psychiatric disease, and also subjects with no available diagnosis label. We
also chose 18 as the minimum age to cover adulthood and also to avoid the neu-
rodevelopmental stage. This results in 10,158 MRI sessions from 6,142 unique
subjects, the statistics are summarized in Table 1.
However, as shown in Figure 2.1 A and B, where we illustrate the age distri-
bution of the 10,158 sessions and 6,142 subjects respectively, the age distribution
of the population is poorly balanced. Although there are studies covering the
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full age span including normal aging studies Cam-CAN [18], IXI, SALD [19],
DLBS [20], OASIS-1 [21], and consortium-based studies such as CoRR [22],
SchizConnect [23], many of the public imaging studies either focused on age-
related disease in the elderly population including ADNI, AIBL [24], OASIS-2
[25], PPMI [26], NIFD; or on young subjects including BGSP [27], SLIM [28]. To
alleviate the potential bias toward a certain age segment, we sought to balance
the age distribution that we ultimately use in the training population.
In this study, when constructing the dataset to be uniform across age-span,
we adopt both ‘oversampling’ and ‘undersampling’. Briefly, we oversample sub-
jects from age ranges with fewer subjects by including the longitudinal follow-up
sessions from the same subjects, which could be regarded as a natural augmen-
tation. For age ranges with more subjects, we only include one scan per subject
to increase the variability of the sample. If that number is still above the mini-
mum across age bins, we further undersample stratified on confounding factors
including acquisition site and gender.
We stratify the populations into age bins and use the bin with the minimum
number of subjects as the basis number. The age bins used in this study are
[18, 20), [20, 25), [25, 30), ... , [85, 90), [90, 100).
One interesting observation is that the [35, 40), [40, 45) are the two age bins
with fewest number of subjects, so we use the number of subjects in this age
segment as the base level and allow repeated scans from same subjects. The
other age bins having multiple scans per subject are the two age bins at the tail
end: [85, 90) and [90, 100], because of the relative lower number in these two
age bins. We undersample the subjects in all other bins.
The final dataset consists of 2,852 MRI sessions from 2,694 subjects covering
age range 18-97, with the mean age 54.34 years old, standard deviation 21.16
years old. The age distribution of the evenly-sampled adult age span dataset is
shown in Figure 2.1 C.
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Figure 1: The age distribution of the study population. A) The age distribution of the raw
dataset consisted of 10,158 MRI sessions; B) the age distribution of the dataset consisted of
6,142 unique subjects; C) the age distribution of the evenly sampled dataset.
2.2. Experimental setup
We design training, validation and test sets of subjects for model training and
evaluation. We build a validation set reflecting of general MRI scan distribution
and population distribution. Similarly, a test set representative of the same
population as the training and validation sets is important for evaluation.
Given this uniform age-distributed dataset we described in the section above,
we perform stratified split based on acquisition sites and gender within each age
bin: 8/10 as training set, 1/10 as validation set, 1/10 as test set, ensuring non-
overlapping subjects and similar distribution of age, gender and acquisition sites
in the training, validation and test sets.
We also evaluate our model by testing it on an independent test set: Cam-
CAN. Aiming to study the normal aging process through the adult life-span,
Cam-CAN provided even age distribution across adult life-span and was previ-
ously used as an independent testing sample in another age estimation study
[13]. We note that the trained model should be applicable to any similarly
8
acquired structural neuroimaging within this age range. However, the result
on an independent sample, which usually reflects a homogeneous population or
acquisition setting, might be over- or under-optimistic.
Additionally, we also perform a test-retest experiment using an indepen-
dent dataset of three subjects scanned 40 times in 30 days [29] to evaluate the
reproducibility of the model.
2.3. MRI Preprocessing
We apply basic pre-processing steps including nonparametric nonuniform
intensity normalization (N3) based bias field correction [30], brain extraction
using FreeSurfer [31], and affine registration to the 1mm3 isotropic MNI152
brain template with trilinear interpolation using FSL FLIRT [32]. The dimen-
sion of the 3D volume is 182× 218× 182 (LR×AP×SI).
All the preprocessed scans were checked by a well-trained reviewer with vi-
sual inspection. Scans having obvious and severe MRI artifacts, brain extraction
failure or poor registration were excluded.
2.4. Convolutional neural network
We use a three-dimensional convolutional neural network (3D-CNN) regres-
sion model for age estimation, with similar architecture as the 3D-CNN clas-
sification model for Alzheimer’s disease classification used in [33]. We follow
a general CNN architecture similar to the VGG classification architecture [34]
with multiple interleaved convolutional blocks and max pooling layers and an
increasing number of features along the depth. We replaced all 2D operations
with 3D operations and included one fully-connected layer to reduce the num-
ber of parameters. We use convolutional layers with kernel size of 3 × 3 × 3,
rectified linear unit (ReLU) as the activation function, and batch normalization
(BN) layers before the activation functions. We flatten the output from the
last convolutional layer and feed into a fully-connected (FC) layer. And the
final activation is a linear operation instead of a softmax in classification tasks.
We include weight l2 regularization to prevent overfitting with a factor of 1.0.
9
The algorithm was optimized using Adam algorithm with mean absolute error
(MAE) loss function, and with a batch size of 5. The initial learning rate was
tuned in the range from 1e− 4 to 1e− 6 including [1e-4, 5e-5, 2e-5, 1e-5, 5e-6,
2e-6, 1e-6] and was set at 2e-5.
We implemented the algorithm using Keras and TensorFlow. An illustration
of the framework is shown in Figure 2. In this study, we use five (N in Figure 2)
stages. The feature dimension of the first layer is 16 and increases by a factor
of 2 in each subsequent stage. The optimal model is selected as the model with
the lowest validation MAE.
Figure 2: The convolution neural network architecture. The inputs are 3D brain volumes.
Each cube represents one 3D feature map. The size of the cube reflects the spatial dimension
of the feature map, the number of the cubes reflects the number of feature maps (channel
dimension) at a specific depth. The blue arrow denotes 3D convolution operation with rectified
linear unit (ReLU), the green arrow denotes 3D convolution followed by batch normalization
(BN) and ReLU, the yellow arrow denotes the max pooling operation. The basic unit enclosed
in the bracket is repeated N = 5 times with increasing number of features and decreasing
spatial dimension. The final convolutional output is flattened and fed into one fully-connected
(FC) layer with linear output (red arrow), generating the final brain age prediction.
2.5. Comparison with model trained on unbalanced dataset
We also trained the model using all scans from unique subjects (N = 6,142,
Figure 2.1 B). We applied the trained model on the independent Cam-CAN
10
dataset and studied the distribution of MAE over chronological age groups.
Besides, a simple way to potentially correct the imbalance without adjusting
the sampling of the dataset is re-weighting the samples, specifically, we assign
different weights to different sample, with the weights in proportional to the in-
verse of the frequency of specific age segments. We note that while importance
weighting is a principled statistical technique with well-known effects in tradi-
tional statistical models, its impact on the learned predictors in deep learning
algorithms are a subject of active inquiry [35].
2.6. Neuropsychological and morphometric associations
To test the utility of the estimated age in studying cognitive functions across
adult life-span, we evaluate the association between the summary scores of Ben-
ton face recognition test (BFRT) and the estimated age in Cam-CAN dataset.
Specifically, we use the signed difference of the estimated age and chronolog-
ical age to reflect the deviance of individual brain age from their chronological
age, and we refer to this value as agediff hereinafter. The BFRT is a commonly
used neuropsychological instrument that can be easily and reliably adminis-
tered in adult patients to test baseline visual memory and perception [36]. We
adopted the SubScore-1, SubScore-2, TotalScore (SubScore-1 + SubScore-2) as
dependent variables in individual linear regression models incorporating gender,
chronological age, agediff , and the interaction of chronological age and agediff :
Score ∼ βageage + βagediffagediff + βagediff×ageage× agediff + βgendergender
Additionally, we evaluate the association between agediff with cortical thick-
ness generated using FreeSurfer [37] by performing a partial correlation with
gender and chronological age as covariates. FreeSurfer parcellates the cortex
into 68 cortical regions.
2.7. Age activation map
Class activation mapping [38, 39] is a commonly-used method for inter-
preting the classification using CNNs and has been previously used in CNN
11
based medical image analysis [40] to marry potential disease pathology with
classification findings. In this work, we use the idea of a class activation map
in a regression setting by highlighting the small-valued gradient in grad-CAM
framework. We use functions in the keras-vis package (https://github.com/
raghakot/keras-vis/). We generate the average activation map within each
age group to investigate the age-specific pattern of underlying substrates for age
estimation.
2.8. Slice based age estimation
Besides the post hoc saliency map based activation map method, we also
propose an ablation analyses method focusing on part of the input data. We
apply serial 2D CNNs for age estimation with the input being three consecutive
slices along each axis. By doing so, we take into consideration the inter-subject
alignment precision (i.e. not using just one slice) and also the similarity among
different channels (i.e. not using five slices). The network architecture of the
2D CNN is the identical to the 3D CNN architecture described in the previous
section with the 3D operations replaced with the corresponding 2D operations.
We report the predictive performance on various sets of 2D slices to analyze
predictive importance.
2.9. Lobe based age estimation
Besides sliced based age estimation, we propose using another more
anatomically-informed way to study the regionality through ablation experi-
ments at the lobar level. The individual lobe masks were generated following a
previous study [33]. The ages are estimated using each lobe individually.
3. Results
3.1. Age prediction
In the hold-out test set, whose instances are distributed identically as the
training and validation set, our model achieves an MAE of 4.06 years and cor-
relation coefficient r = 0.970.
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Figure 3: The estimated age versus chronological age in an independent test set of adult
life-span.
An independent normal aging life-span dataset—Cam-CAN—was tested in
a previous brain age study [13]. In that study, when the Cam-CAN data were
pre-processed with the optimal parameters selected from the independent train-
ing sample, their proposed model achieved an MAE of 6.08 years and correlation
coefficient r = 0.929. We tested out our model in Cam-CAN study processing
the T1w MRI images using the same pipeline as the other samples. The rela-
tionship between the estimated age and chronological age in Cam-CAN is shown
in Figure 3.1. The correlation coefficient r is 0.960, MAE is 4.21 years, which
outperforms the result in the previous study [13]. We also observe two obvi-
ous “outliers” among the 652 subjects tested, further investigation is needed to
pinpoint potential sources of error, either methodological, constitutional or true
poor estimation. The results demonstrate our proposed model achieves accurate
estimation in all age segments.
13
Table 2: Reproducibility experiment result
subject actual age predicted age mean predicted age std
subj-1 26 25.19 1.07
subj-2 31 33.02 1.14
subj-3 30 27.06 0.81
Figure 4: The distribution of predicted ages in test-retest scans.
3.2. Reproducibility
We evaluate the reproducibility of the algorithm in test-retest acquisitions.
We show the results in Table 2 and Figure 4, observing that there is a difference
in the estimated age and actual reported chronological age that is consistent
over the sessions with approximately a 1 year standard deviation.
3.3. Comparison with results using nonuniform dataset
We compare the results using nonuniform dataset with the MAE perfor-
mance in Cam-CAN dataset. Using the nonuniform dataset achieves compara-
ble overall MAE (4.27 years) as the balanced data. Re-weighting the samples
helps slightly improves the MAE (4.17 years) than the balanced dataset despite
using many more scans. Additionally, we observe the MAE using the nonuni-
form dataset is not evenly distributed across life-span: MAE is lower in the
14
Table 3: Association with Benton face recognition scores
Score
age age diff age diff × age
β p β p β p
SubScore-1 -2.51e-3 3.01e-6 -0.0127 0.0297 2.62e-4 0.0102
SubScore-2 -0.0605 1.24e-32 -0.157 2.90e-3 2.31e-3 0.0119
TotalScore -0.0630 5.07e-34 -0.170 1.54e-3 2.57e-3 5.88e-3
young age with more abundant data, as shown in Figure 5 (B). This could in-
troduce potential bias in life-span studies. Using sample re-weighting (Figure 5
(C)) alleviates the problem and using balanced dataset generates generally even
distribution across age-span (Figure 5 (A)).
Figure 5: Distribution of MAE across life-span. (A) Age estimated using the balanced dataset.
Each step in the red line indicate the MAE in that age group, the black dashed line indicates
the overall MAE. (B) Age estimated using the nonuniform dataset. (C) Age estimated using
the nonuniform dataset but with sample re-weighting.
3.4. Neuropsychological and neuromorphometric association
The association of the BFRT scores with the difference in the estimated
age and the chronological age and its interaction with chronological age are
summarized in Table 3.
The association of the cortical thickness measures with the agediff is illus-
trated in Figure 6. The thickness of cortical regions are significantly associated
with the agediff . In addition, out of the 68 regions measured, 51 regions have
15
a stronger correlation with the estimated age than the chronological age. This
is expected as the age estimated through structural MRI image is in principle
more coupled to structural phenotypes.
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Figure 6: The partial correlation coefficients of agediff and cortical thickness measures. The
red dashed line indicates α = 0.05 under multiple comparison of N=34 regions.
3.5. Age activation map
We expect the anatomical patterns characterizing different age groups to be
different throughout lifetime but are consistent within a local age range. Thus
we generate and illustrate the age activation maps every 5 years, in the same
way as preparing the dataset. The 3D iso-surfaces of the average age activation
maps are shown in Fig. 7. The average age activation maps overlaid on the
MNI152 template are shown in Fig. 8 (Left). To accommodate the anatomical
differences in different age groups, we also generated average T1w image within
each age group, and overlaid the corresponding age activation map, as shown
in Fig. 8 (Right).
16
Figure 7: The 3D iso-surfaces (0.8) of the age activation maps at different age groups.
3.6. Slice based age estimation
The age estimation performance using 2D MRI slabs sliced at different co-
ordinate planes is shown in Figure 9. The slices with the best performance are
also illustrated.
3.7. Lobe based age estimation
The MAE trained using different lobes are shown in Table 4, where we show
the best estimation performance achieved through frontal lobe. And temporal
lobe achieved marginally lower performance.
Table 4: Lobe based age estimation
Lobe Frontal Temporal Parietal Occipital Cerebellum Whole-brain
MAE 5.33 5.81 6.37 7.66 6.2 0 4.06
4. Discussion
In this study, a large heterogeneous dataset of structural neuroimaging across
the adult lifespan was aggregated from multiple publicly available data sources.
17
Figure 8: The age activation maps at different age groups overlaid on the (Left) MNI152
template, and (Right) average T1w image within each age group, both with threshold at 0.8.
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Figure 9: MRI 2D slice based age estimation. (Top row) The mean absolute error (MAE) of
the estimated age on the test set using 2D slices at different locations, the red lines indicate
the location with lowest MAE. MAEs larger than 10 are capped to 10 for illustration purpose.
(Bottom row) The illustration of slices at the red lines in the top row from the MNI152
template and the corresponding segmentation (the colors follow the FreeSurfer color lookup
table).
19
A deep convolutional neural network was developed, trained and applied to
predict the chronological age from the subject’s scan.
This uniformly distributed dataset is able to achieve estimation without ap-
preciable bias towards a certain age group, while maintaining training efficiency
compared with training on an nonuniform dataset. While this study aims to
examine the aging process across the adult life-span, other studies aiming to
examine the role of aging in other conditions would likely benefit from other
specific training dataset inclusion criteria. For example, for studies of autism
and prodromal psychosis where age of onset skews younger, studies would re-
quire the inclusion of subjects below 18, and subjects in middle and old age
would likely be less informative.
The regionality analysis in this study reveals patterns of neuroanatomical
contributions of normal aging. All analyses provide evidence for the promi-
nence of frontal regions in all epochs of age estimation in the adult lifespan.
Frontal regions have been implicated in normal aging through both neuropsy-
chological studies and neuroimaging studies [41, 42, 43]. In addition, the pattern
shifts reflected in the age activation map based analysis imply a frontal lobe-
focused locus of age-related structural changes. Neuropsychological evaluations
targeting different cognitive domains and brain regions might help reveal the
underlying complexity in the aging-process.
Our analysis revealed the association between the divergence of estimated
age from chronological age and BFRT performance. This suggests the potential
utility of the estimated age at normal aging evaluation, in complement to other
cognitive test and neuroimaging based measures. The utility relates to an open
question of the aging process. It still requires further validation how a scan’s
predicted deviance would reveal an individual’s brain health status or even
trigger clinical evaluations, since while inter-subject differences in normal aging
process exist, they are not well understood. Moreover, it is unclear whether
this inherent variability increases with age or stays constant throughout the
life-span.
One consideration is that the set of subjects with no current pathological
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symptoms might have disease at asymptomatic prodromal state that have yet
to manifest in the clinical evaluation, such as pre-clinical AD. Such work would
require follow-up data to preclude disease for a given period of time such that
they remain stable as controls. However, this was not available for all subjects,
and in a group of otherwise healthy individuals, it is likely that some healthy
individuals do harbor occult disease. Additionally, subjects were considered
normal using criteria germane to the disease of focus in different studies.
Given the diversity of the studies from which the model was trained, the
protocols and acquisitions vary across both site and study. This in fact benefits
this model compared to individual studies of unified aging because the variance
of acquisition differences are included in the training, compared to training data
where a more cohesive protocol is used. Such inclusion without appreciable loss
of accuracy supports the use of this model on a wider variety of baseline scans.
5. Conclusion
This study has demonstrated the high accuracy of an age estimation frame-
work using routine structural neuroimaging and a deep convolutional neural
network, trained on a large-scale healthy population with uniform age distri-
bution across adult age span. While there is considerable interest and value
in a highly accurate estimation model that can be applied to a wide variety of
structural MRI protocols, this study also demonstrates patterns of the regional
contributions of aging across the lifespan using multiple methods, agnostic of
tissue classes, structure delineation or surface parcellation. This framework can
be used to generate meaningful quantitative and visual biomarkers for both ag-
ing studies and broad neuroimaging applications. Further studies may examine
the estimated age and the regional contributions to see if they may be useful
in understanding one’s age divergence in the context of a particular disease or
condition’s pathology.
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Supplementary Material
Table S1: Distribution of number of scans per subject
number of scans per subject 1 2 3 4 5 6 7
number of subjects 2598 59 19 6 6 3 1
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